Gary Hoffman, M.D.
| Appointed: |
1992 |
| Gender: |
Male |
| Languages: |
English |
Rheumatologic and Immunologic Disease
Professional Staff Affairs Office
Director of Senior Staff Matters
Biographical Sketch
Gary S. Hoffman, MD, MS, received his medical degree from the Medical College of Virginia and pursued advanced training in Medicine and Rheumatology at Dartmouth Medical School. He is the Harold C. Schott Chair for Rheumatic and Immunologic Diseases, Founder of the Cleveland Clinic Center for Vasculitis Care and Research, Founder and past Chairman of the International Network for the Study of the Systemic Vasculitides (INSSYS), Chairman of the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic and Professor of Medicine at Lerner College of Medicine.
Prior to joining Cleveland Clinic, he was the Head of Vasculitis and Related Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Dr. Hoffman has led investigations of new therapies for the treatment of the systemic vasculitides. His work includes the coordination of INSSYS-based multi-center studies of new treatments and diagnostic tools to assess vasculitis disease activity. His laboratory is studying factors that may be involved in determining organ vulnerability and selective targeting in vasculitis.
Among the numerous awards he has received for contributions to vasculitis research are the NIH Director's Award, the NIAID Director's Award, the Wegener's Foundation Award for Excellence in Clinical Research, the William Ischmael, Pemberton Awards and the Maria and Sam Miller Clinical Research Award. He has been repeatedly listed among the “Best Doctors in America” and has also received awards for excellence in teaching medicine.
Dr. Hoffman is on the Editorial Boards of numerous rheumatology journals is the Editor of Inflammatory Diseases of Blood Vessels. Dr. Hoffman is a past member of the Board of Directors of the American College of Rheumatology, serves on The FDA Advisory Board and Boards of numerous lay organizations whose goals are to educate patients and support research in vasculitis.
Professional Highlights
- Former Head of Vasculitis and Related Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
- Led investigations of new therapies for the treatment of the systemic vasculitides
Education & Fellowships
| Medical School: | Virginia Commonwealth University Medical College, Richmond, VA |
|
| Internship: | Riverside Regional Medical Center, Medical Internship, Newport News, VA |
| Residency: | Dartmouth Medical School, Internal Medicine, Hanover, NH |
| Fellowship: | Dartmouth Medical School, Rheumatology, Hanover, NH |
| Other Education: | (Graduate) Howard University, Washington, DC |
| Other Education: | (Undergraduate) State University of New York at Binghamton, Binghamton, NY |
Certifications
Rheumatology
Internal Medicine
Specialty Interests
Vasculitis.
Innovations & Patents
Patent: Cid MC, Grant DS, Hoffman GS, Kleinman HK: For “Method of stimulating angiogenesis by using haptoglobin,” U.S. Patent Serial No. 07/939, 142, accepted 1993. Issued #5,318,957; June 7, 1994
Awards & Honors
-
Golden Apple Award for teaching excellence, 1985
-
Awards for Teaching Excellence, 1995, 1998
-
National Institutes of Health, NIAID Director's Award, 1990, 1992
-
NIH Director's Award, 1992
-
Chairman and Founder, International Network for the Study of Systemic Vasculitis, 1991-2001
-
Honorary Member of the Chilean Society of Rheumatology, 1995
- “Best Doctors in America: General Rheumatology,” 1996-2007
- Castle Connolly’s “America’s Top Doctors,” 2001-2007
-
The Twenty-Second Annual William K. Ishmael Award and Lectureship in Rheumatology (1996), University of Oklahoma
-
Mexican Society of Rheumatology, Annual Visiting Professor, 1998
-
National Institutes of Health, National Institute of Allergy and Infectious Diseases Advisory Panel for Vasculitis Research, 1998
-
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, long range planning panel, 1999
-
Senior Faculty Host Coordinator for the ACR/EULAR International Exchange Program, 2000- 2001
-
Board of Directors, American College of Rheumatology, 2000-2003
-
Tisdale Memorial Lecture, University of Vermont, 2000
-
Awarded Harold C. Schott Chair in Rheumatic and Immunologic Diseases, 2000
-
JFL Woodbury Lecture, Dalhousie University, 2001
-
Sommer Memorial Lecture Series, Portland 2001
-
Keynote and Co-Chair, Vasculitis. Japanese Society of Rheumatology, 2001
-
Program Director/Host, International Vasculitis and ANCA Workshop. 2002
-
The Simon Dworkin Visiting Professor, McGill U. Medical Center. June 2002
-
The Inaugural Gene Hunder Lecture. 2nd International Conference on GCA/PMR, Mayo Clinic, August, 2002
-
54th Annual Pemberton Lecture and Award: Pathogenesis of Large Vessel Vasculitis – What makes a vessel a target? Oct., 2004
2005 Israeli Society of Rheumatology, Keynote Presentation: The use of biologic therapies in systemic vasculitis
-
2006 keynote speaker: Lund Vasculitis Symposium, Sweden
-
Cleveland Clinic Miller Award for Scientific Achievement in Clinical Research, 2007
Professional Memberships
- Fellow, American College of Physicians
- Fellow, American College of Rheumatology
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Hoffman has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
